Search

Your search keyword '"Franck Mouthon"' showing total 2 results
Start Over Author "Franck Mouthon" Journal therapies
2 results on '"Franck Mouthon"'

1. Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?

Author

Régis Bordet, Jean-Christophe Dantonel, Eric Vacaresse, Claire Le Jeunne, Nora Benhabiles, Alain Beretz, Christian Boitard, Stéphanie Debette, Gilles Duluc, Philippe Froguel, Bénédicte Garbil, Stanislas Lyonnet, Abderrahim Mahfoudi, Pierre Marquet, Franck Mouthon, Olivier Rascol, Vincent Richard, Emmanuelle Simon, Nathalie Varoqueaux, Hervé Watier, and Marie Zins

Subjects
Pharmacology (medical)
Published
2022

2. Innovative approaches in CNS drug discovery

Author

Luc Zimmer, Mathieu Charvériat, Vincent Lafon, Franck Mouthon, Theranexus [Lyon], Insiliance, Hospices Civils de Lyon (HCL), Centre de recherche en neurosciences de Lyon (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Etude et de Recherche Multimodal Et Pluridisciplinaire en imagerie du vivant (CERMEP - imagerie du vivant), and Université de Lyon-Université de Lyon-CHU Grenoble-Hospices Civils de Lyon (HCL)-CHU Saint-Etienne-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)

Subjects
Big Data, medicine.medical_specialty, Neurology, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging, Big data, 030226 pharmacology & pharmacy, 03 medical and health sciences, Neuropharmacology, 0302 clinical medicine, Artificial Intelligence, medicine, Animals, Humans, Pharmacology (medical), Intensive care medicine, Drug discovery, business.industry, Translational, Biomarker, 3. Good health, Central nervous system, Therapeutic Area, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], business, Central Nervous System Agents
Abstract

International audience; Central nervous system disorders remain the leading causes of mortality and morbidity worldwide, affecting more than 1 billion patients. This therapeutic area suffers from high unmet medical needs and the search for innovative approaches to identify therapeutic strategies is urgent in the field. This review will first cover the challenges and opportunities of drug discovery in neurology, and then as well as the new models, such as human model stem cells and animal models under development in the field. In addition, innovative and translational neuroimaging techniques will be discussed, as the use of big data and artificial intelligence to discovery new drugs in neurological and neuropsychiatric disorders.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results